Showing results (451-460 of 468) with videos related to
Sort By:
Pageof 47
Neoplasia (New York, N.Y.)|March 17, 2026
CCAAT-enhancer binding protein delta functions as a tumor suppressor gene in acute myeloid leukemiaSubhash C Prajapati, Cem Meydan, Yaseswini Neelamraju, et al.Clinical Transplantation|April 28, 2025
Rethinking the Diagnosis and Management of Antibody-Mediated Rejection in Multidisciplinary Transplant Meetings: A Global Survey and Banff Working Group RecommendationsRuth Sapir-Pichhadze, Medhat Askar, Matthew Cooper, et al.Microbiome|April 3, 2020
Lung function and microbiota diversity in cystic fibrosisLeah Cuthbertson, Alan W Walker, Anna E Oliver, et al.American Journal of Hematology|June 19, 2023
Real-world effectiveness of intensive chemotherapy with 7&3 versus venetoclax and hypomethylating agent in acute myeloid leukemiaAndrew H Matthews, Alexander E Perl, Selina M Luger, et al.Nature|October 29, 2020
Single-cell mutation analysis of clonal evolution in myeloid malignanciesLinde A Miles, Robert L Bowman, Tiffany R Merlinsky, et al.Ebiomedicine|February 26, 2022
Protease-anti-protease compartmentalization in SARS-CoV-2 ARDS: Therapeutic implicationsOisin F McElvaney, Takanori Asakura, Suzanne L Meinig, et al.Med (New York, N.Y.)|March 16, 2022
A randomized, double-blind, placebo-controlled trial of intravenous alpha-1 antitrypsin for ARDS secondary to COVID-19Oliver J McElvaney, Natalie L McEvoy, Fiona Boland, et al.Communications Biology|July 7, 2026
Loss of endothelial ZEB1 enhances neovascularisation during choroidal neovascularisationNicholas Beazley-Long, Joseph L Horder, Kathryn R Green, et al.Oncogene|November 28, 2018
Targeting EIF4E signaling with ribavirin in infant acute lymphoblastic leukemiaKaren A Urtishak, Li-San Wang, Biljana Culjkovic-Kraljacic, et al.Blood Cancer Discovery|January 11, 2022
BCOR and BCORL1 Mutations Drive Epigenetic Reprogramming and Oncogenic Signaling by Unlinking PRC1.1 from Target GenesEva J Schaefer, Helen C Wang, Hannah Q Karp, et al.Pageof 47